Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD(2) Antibody

Tekijä Siebert, Nikolai, Seidel, Diana, Eger, Christin, Jüttner, Madlen, Lode, Holger N.
Julkaistu 2014

Full Activation of CD4(+) T Cells Early During Sepsis Requires Specific Antigen

Tekijä Schmoeckel, Katrin, Traffehn, Sarah, Eger, Christin, Pötschke, Christian, Bröker, Barbara M.
Julkaisussa Shock (2015)

Generation and Characterization of a Human/Mouse Chimeric GD(2)-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma

Tekijä Eger, Christin, Siebert, Nikolai, Seidel, Diana, Zumpe, Maxi, Jüttner, Madlen, Brandt, Sven, Müller, Hans-Peter, Lode, Holger N.
Julkaisussa PLoS One (2016)

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Tekijä Siebert, Nikolai, Eger, Christin, Seidel, Diana, Jüttner, Madlen, Zumpe, Maxi, Wegner, Danilo, Kietz, Silke, Ehlert, Karoline, Veal, Gareth J., Siegmund, Werner, Weiss, Michael, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Julkaisussa MAbs (2016)